On November 19, 2021, EPA announced that, with the ongoing public health concerns of COVID-19, the Agency is indefinitely extending its current Emerging Viral Pathogens (EVP) policy for SARS-CoV-2.  What this means for product registrants is that EPA will now provide at least a six month notice before inactivating any existing EVP guidance for SARS-CoV-2 to allow companies ample time to modify their product marketing literature.  For more information, click here